Pathology Reasoning Answers (3 marks each)

1. Why does long standing GERD lead to Barrett's oesophagus?

2. How does Helicobacter pylori infection contribute to the development of peptic ulcers?

• Urease production hydrolyzes urea to ammonia, neutralizing local acid and creating a favorable niche, while ammonia is directly toxic to epithelium.
• Cytotoxins (CagA, VacA) and inflammatory mediators cause direct mucosal damage and disrupt tight junctions.
• Chronic antral gastritis increases gastrin release (loss of somatostatin-producing D cells) leading to hypergastrinemia and increased acid secretion, which overwhelms duodenal bicarbonate defenses (duodenal ulcer pathway).
• Bacterial proteases/phospholipases degrade the protective mucus layer, and the resulting chronic inflammatory infiltrate (neutrophils, macrophages) releases reactive oxygen species that damage the mucosa. The net effect is disruption of the mucosal defense-acid balance, resulting in ulceration (Sleisenger and Fordtran's GI and Liver Disease; Schwartz's Surgery - about 75% of peptic ulcers are attributable to H. pylori).

3. H. pylori Gastritis

4. Justify: "H. pylori is an important risk factor for gastric carcinoma"

• Chronic H. pylori infection is classified as a Class I (definite) carcinogen by IARC.
• It drives the Correa multistep cascade: chronic superficial gastritis -> chronic atrophic gastritis -> intestinal metaplasia -> dysplasia -> intestinal-type adenocarcinoma, mainly affecting the body/antrum.
• Persistent inflammation generates reactive oxygen/nitrogen species causing DNA damage; CagA-positive strains are injected into epithelial cells and disrupt cell polarity and signaling, promoting proliferation.
• Infection also predisposes to gastric MALT lymphoma via chronic antigenic B-cell stimulation, which can regress with H. pylori eradication - direct proof of a causal pathogenic role.
• Epidemiologically, populations with high H. pylori prevalence have correspondingly higher rates of distal gastric cancer, and eradication trials reduce (though do not eliminate, especially once metaplasia has set in) cancer incidence (Yamada's Gastroenterology, Maingot's Abdominal Operations - Correa model).

5. Four major morphological differences between Benign and Malignant Gastric Ulcer

6. Why do patients with stomach cancer develop bilateral ovarian swelling?

• Transcoelomic (peritoneal) seeding - tumor cells exfoliate into the peritoneal cavity and implant on the ovarian surface, which is highly vascular and receptive to seeding.
• Retrograde lymphatic spread via para-aortic and pelvic lymphatics.
• Hematogenous spread in some cases. Because both ovaries share similar lymphovascular drainage and mesenteric proximity, metastasis is characteristically bilateral, producing solid, mucin-filled ovaries with signet-ring cells infiltrating a proliferated ovarian stroma (Berek & Novak's Gynecology; Sleisenger and Fordtran's).

7. Why does melena develop in lower GIT obstruction?

• Stasis of luminal contents proximal to the obstruction prolongs the transit time of any blood present (from ulceration, mucosal ischemia, or a bleeding tumor at/proximal to the obstruction).
• The prolonged bacterial action and enzymatic degradation of hemoglobin during this stasis produces the black, digested appearance typical of melena, even though the bleeding source is not necessarily in the upper GI tract.
• Note classically melena implies bleeding proximal to and stasis within the colon is less commonly a cause; when the obstructing lesion itself ulcerates and bleeds slowly with the retained/stagnant bowel content, digested blood can still present as melena rather than fresh hematochezia (Tintinalli's Emergency Medicine).

8. Why is hormone receptor (ER/PR) status determined in breast carcinoma?

1. Prognostic value - ER/PR-positive tumors tend to be better differentiated, grow more slowly, and have a more favorable prognosis than receptor-negative tumors.
2. Predictive/therapeutic value - Receptor-positive tumors respond to endocrine therapy (tamoxifen, aromatase inhibitors), which blocks estrogen-driven proliferation; receptor-negative tumors will not respond and need alternative (chemo/targeted) therapy.
3. Guides adjuvant treatment selection alongside HER2 status, forming the basis of breast cancer molecular subtyping (Luminal A/B vs HER2-enriched vs triple-negative), which determines the overall treatment algorithm and long-term surveillance strategy (Robbins Pathologic Basis of Disease; Washington Manual).

9. Role of the triple test in evaluation of a palpable breast lump

1. Clinical breast examination - assesses size, consistency, fixity, skin/nipple changes.
2. Imaging - mammography and/or ultrasonography, assessing radiological features of malignancy (spiculated margins, microcalcifications).
3. Fine needle aspiration cytology (FNAC) or core biopsy - provides cytological/histological confirmation.

10. 45-year-old with bloody vaginal discharge, post-coital bleeding, ulcerative growth on anterior cervical lip - Etiopathogenesis and screening

• The central causative agent is persistent high-risk HPV infection (chiefly types 16 and 18), transmitted sexually.
• HPV E6 and E7 oncoproteins inactivate the tumor suppressors p53 (E6) and Rb (E7), abrogating cell cycle checkpoints and apoptosis, allowing unchecked proliferation of infected basal squamous cells at the transformation zone (squamocolumnar junction).
• This drives progressive dysplastic change: CIN 1 (mild) -> CIN 2 (moderate) -> CIN 3/carcinoma in situ (severe) -> invasive squamous cell carcinoma once the basement membrane is breached.
• Cofactors that promote persistence/progression: early coitarche, multiple sexual partners, multiparity, smoking, immunosuppression (HIV), long-term oral contraceptive use, and other STIs.
• Most HPV infections and low-grade CIN regress spontaneously via host immune clearance; progression occurs mainly with persistent high-risk HPV integration into the host genome.

11. How is the APC/β-catenin pathway related to adenocarcinoma of the colon?

• In the resting (Wnt-inactive) state, APC forms a destruction complex (with Axin and GSK-3β) that phosphorylates cytoplasmic β-catenin, targeting it for ubiquitination and proteasomal degradation - keeping intracellular β-catenin levels low.
• When APC is mutated or lost (as in familial adenomatous polyposis and most sporadic colon cancers via the classic adenoma-carcinoma sequence), β-catenin escapes degradation, accumulates in the cytoplasm, and translocates to the nucleus.
• Nuclear β-catenin binds TCF/LEF transcription factors, driving expression of proliferative and oncogenic genes such as cyclin D1 and c-MYC.
• This constitutive Wnt activation blocks terminal differentiation of colonic enterocytes and drives unchecked proliferation of crypt epithelium, initiating adenoma formation; subsequent mutations (KRAS, TP53, additional chromosomal instability) drive progression to invasive adenocarcinoma.
• Loss of APC is considered the initiating/gatekeeper event in the majority of sporadic colorectal cancers (Robbins Pathologic Basis of Disease; Sabiston Textbook of Surgery).

Pathology Reasoning Answers (3 marks each)

1. Cigarette smoking and, to a much lesser extent, other environmental carcinogens are responsible for the mutations giving rise to lung cancer. Justify.

• Tobacco smoke contains over 60 identified carcinogens (polycyclic aromatic hydrocarbons like benzo[a]pyrene, nitrosamines such as NNK, aromatic amines, and free radicals) that undergo metabolic activation by cytochrome P450 enzymes to form reactive electrophilic intermediates.
• These intermediates form DNA adducts, producing characteristic mutational signatures (e.g., G:C to A:T transversions) in critical growth-regulatory genes: activation of oncogenes (KRAS, MYC) and inactivation of tumor suppressor genes (TP53, RB, p16/CDKN2A).
• A clear dose-response relationship exists: risk rises with number of cigarettes/day, duration of smoking, and age of onset; risk falls after cessation, supporting causality.
• Molecular epidemiology confirms tobacco-specific mutational signatures in lung tumors of smokers that are distinct from those in never-smokers.
• Other environmental carcinogens (asbestos, radon, industrial chemicals like arsenic and chromium, air pollution, ionizing radiation) also cause lung cancer, but their population-level contribution is far smaller than tobacco, and many act synergistically with smoking (e.g., asbestos + smoking multiplies risk rather than simply adding to it) rather than independently.
• This combination of a plausible causal mechanism (carcinogen -> DNA adduct -> mutation -> oncogenic activation), a dose-response relationship, and epidemiological data justifies smoking as the dominant etiological factor, with other carcinogens contributing a much smaller attributable fraction (Robbins Pathologic Basis of Disease).

2. Why does oedema occur in kwashiorkor? Differences between Marasmus and Kwashiorkor

3. Types of emphysema and why Alpha-1 antitrypsin (A1AT) deficiency causes emphysema

1. Centriacinar (centrilobular) emphysema - affects the central/proximal respiratory bronchioles, sparing distal alveoli; most common type, strongly associated with cigarette smoking; predominates in upper lobes.
2. Panacinar (panlobular) emphysema - uniform destruction of the entire acinus from respiratory bronchiole to terminal alveoli; classically associated with A1AT deficiency; predominates in lower lobes.
3. Paraseptal (distal acinar) emphysema - affects the distal part of the acinus adjacent to pleura and septa; associated with spontaneous pneumothorax in young adults (bullae formation).
4. Irregular emphysema - scarring-associated, irregular acinar involvement, usually asymptomatic and associated with healed inflammatory scars.

• Alpha-1 antitrypsin is the principal inhibitor of neutrophil elastase, a proteolytic enzyme released by neutrophils during normal/inflammatory turnover in the lung that can digest elastin in alveolar walls.
• Normally, a protease-antiprotease balance exists in the lower respiratory tract, protecting elastin and other structural connective tissue.
• In genetic A1AT deficiency (commonly the PiZZ genotype, due to a misfolded protein that cannot be secreted from hepatocytes and accumulates in the liver instead), circulating and lung levels of A1AT fall to a fraction of normal (as low as 15%).
• This shifts the balance toward unopposed elastase activity, causing progressive destruction of the alveolar elastic framework, panacinar loss of alveolar septa, and permanent airspace enlargement, i.e. emphysema - occurring at a younger age and more severely than smoking-related emphysema.
• Cigarette smoking dramatically accelerates this process in A1AT-deficient individuals by simultaneously increasing neutrophil/macrophage recruitment (more elastase release) and directly oxidizing and inactivating residual A1AT, further tipping the protease-antiprotease balance toward tissue destruction (Robbins Pathology; Fishman's Pulmonary Diseases and Disorders).